Andreas Karagiannis UROLOGIST

• PhDc – Focal therapy for prostate cancer using the Nanoknife system

   

• European Association of Urology (EAU)
• South Eastern European Robotic Surgery Society (SEERSS)
• Hellenic Urological Association (HUA) – Section of Endourology and Laparoscopic/Robotic Urology – Urotechnology
• Hellenic Urological Association (HUA) – Section of Urogenital Oncology
• South Eastern Group for Urolithiasis Research (S.E.G.U.R.)

• Affiliated Urologist, Hygeia Hospital (since 2018)
• Affiliated Urologist, Mitera Hospital (since 2018)
• Director, 1st Urology Department, Euroclinic of Athens (since 2025)
• Scientific Director, General Health Care Center (since 2022)
• Consultant Urologist, 1st Urology Department, Euroclinic of Athens (2018–2024)
• Affiliated Urologist, Athens IVF Center (since 2018)
• Fellowship in Robotic Surgery, Department of Urology, Karolinska University Hospital, Stockholm, Sweden (2018)

Teaching Experience

• Trainer in Robotic Surgery during educational programs organized by the Section of Endourology and Laparoscopic/Robotic Urology – Urotechnology of the Hellenic Urological Association.

• Robotic Radical Prostatectomy
• Robotic Partial Nephrectomy
• Robotic Radical Nephrectomy
• Robotic Radical Cystectomy
• Robotic Pyeloplasty
• Ureteroscopic Laser Lithotripsy (Holmium & Thulium)
• Retrograde Intrarenal Laser Lithotripsy (Holmium & Thulium)
• Percutaneous Nephrolithotripsy
• Transperineal 3D Fusion MRI-Guided Prostate Biopsy
• Focal Therapy for Prostate Cancer using Nanoknife
• Transurethral Resection of the Prostate (TURis)
• Aquablation – Robotic Transurethral Prostate Resection

Special Areas of Focus:

• Benign Prostatic Hyperplasia (BPH)
• Endourology – Minimally Invasive Urologic Surgery
• Robotic Surgery for Urologic Malignancies Stone

• Hellenic Urological Association Scholarship – “A. Deliveliotis” Award (1st place, written examination), 2018
• Best Presentation Award, 10th Panhellenic Andrology Congress, 2017

• Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries. MacLennan S, Azevedo N, Karagiannis A, Duncan E, Dunsmore J, Fullwood L, Lumen N, Plass K, Ribal MJ, Roobol MJ, Nieboer D, Schouten N, Skolarus TA, Smith EJ, N’Dow J, Mottet N, Briganti A; Pan-European National Urological Society IMAGINE Collaborative (see Supplemental material for group members affiliations Eur Urol. 2023 May;83(5):393-401
• The Effect of PDE5 Inhibitors on the Male Reproductive Tract. Sofikitis N, Kaltsas A, Dimitriadis F, Rassweiler J, Grivas N, Zachariou A, Kaponis A, Tsounapi P, Paterakis N, Karagiannis A, Skouros S, Giannakis I, Champilomatis I, Paschopoulos M, Daphnis D, Giakoumakis I, R Gabales M, M Chua JB, Lantin Iii PL, Mamoulakis C, Takenaka A.Curr Pharm Des. 2021;27(23):2697-2713
• Translation and Validation of the TANGO Nocturia Screening Tool into Greek. Zachariou A, Filiponi M, Kaltsas A, Dimitriadis F, Sapouna V, Giannakis I, Mamoulakis C, Karagiannis A, Zikopoulos A, Paschopoulos M, Takenaka A, Sofikitis N. J Multidiscip Healthc. 2021 Jul 20;14:1883-1891
• Radiation Exposure of Surgical Team During Endourological Procedures: International Atomic Energy Agency-South-Eastern European Group for Urolithiasis Research Study. Vassileva J, Zagorska A, Karagiannis A, Petkova K, Sabuncu K, Saltirov I, Sarica K, Skolarikos A, Stavridis S, Trinchieri A, Tzelves L, Ulus I, Yuruk E .J Endourol. 2021 May;35(5):574-582.
• Radiation exposure of patients during endourological procedures: IAEA-SEGUR study. Vassileva J, Zagorska A, Basic D, Karagiannis A, Petkova K, Sabuncu K, Saltirov I, Sarica K, Skolarikos A, Stavridis S, Trinchieri A, Tzelves L, Ulus I, Yuruk E. J Radiol Prot. 2020 Nov 20;40(4)
• Irreversible Electroporation for the Ablation of Prostate Cancer. Karagiannis A, Varkarakis J. Curr Urol Rep. 2019 Sep 2;20(10):63.
• A prospective comparative analysis of robot-assisted vs open simple prostatectomy for benign prostatic hyperplasia. Mourmouris P, Keskin SM, Skolarikos A, Argun OB, Karagiannis AA, Tufek I, Obek C, Riza Kural A.BJU Int. 2019 Feb;123(2):313-317.
• Epidemiologic study of urolithiasis in seven countries of South-Eastern Europe: S.E.G.U.R. 1 study. Karagiannis A, Skolarikos A, Alexandrescu E, Basic D, Geavlete P, Maletta A, Muslumanoglu AY, Papatsoris A, Petkova K, Saidi S, Skakic A, Saltirov I, Sarica K, Stavridis S, Yilmaz O, Trinchieri A.Arch Ital Urol Androl. 2017 Oct 3;89(3):173-177
• Serum testosterone as a biomarker for second prostatic biopsy in men with negative first biopsy for prostatic cancer and PSA>4ng/mL, or with PIN biopsy result. Fiamegos A, Varkarakis J, Kontraros M, Karagiannis A, Chrisofos M, Barbalias D, Deliveliotis C.Int Braz J Urol. 2016 Sep-Oct;42(5):925-931